Identification of PTPN1 as a Novel Negative Regulator of the JNK MAPK Pathway Using a Synthetic Screening for Pathway-Specific Phosphatases

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-13494-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

NED416, a Novel Synthetic Sirt1 Activator, Promotes Cutaneous Wound Healing via the MAPK/Rho Pathway

International Journal of Molecular Medicine
MedicineGenetics
2020English

The NF90-NF45 Complex Functions as a Negative Regulator in the MicroRNA Processing Pathway

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2009English

Comment Re: HMGA2 Is a Negative Regulator of DNA-PK Pathway

Cancer Research
Cancer ResearchOncology
2010English

The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer

Journal of Immunology
AllergyImmunology
2013English

The MEK-ERK Signaling Pathway Is a Negative Regulator of Cartilage-Specific Gene Expression in Embryonic Limb Mesenchyme

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

miR-194 Is a Negative Regulator of GEF-H1 Pathway in Melanoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Nucleo-Cytoplasmic Shuttling of Axin, a Negative Regulator of the WNT-Β-Catenin Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Identification of CITED2 as a Negative Regulator of Fracture Healing

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2009English

miR-141-3p Is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy